Literature DB >> 6625989

Persisting neurologic sequelae of lithium carbonate therapy.

I M Donaldson, J Cuningham.   

Abstract

Persisting neurologic damage rarely follows lithium salt therapy. We encountered two cases and found 15 others in the literature. There are usually signs of damage at multiple sites in the nervous system, but cerebellar features tend to be most prominent. The patient's sex and age, the lithium ion dosage, and the maximum blood levels of lithium ion do not correlate well with the persistence of damage. Individual susceptibility may be important. Severe lithium ion intoxication may occur in the first one or two months after the drug is introduced but can arise even after several years of satisfactory maintenance therapy at a constant dosage. Infection, dehydration, deteriorating renal function, or the addition of other drugs to the regimen may precipitate acute toxicity. Neurologic damage can occur despite low plasma levels of lithium ion. The patient's clinical state may be the best indication of intoxication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6625989     DOI: 10.1001/archneur.1983.04050110065011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  A Creutzfeldt-Jakob like syndrome due to lithium toxicity.

Authors:  A Primavera; G Brusa; M G Poeta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

3.  The syndrome of irreversible lithium effectuated neurotoxicity.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

4.  Cerebellar syndrome in lithium poisoning.

Authors:  D E Jacome
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

5.  Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs.

Authors:  J Mani; S V Tandel; P U Shah; D R Karnad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 6.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 7.  Permanent Cerebellar Degeneration After Acute Hyperthermia with Non-toxic Lithium Levels: a Case Report and Review of Literature.

Authors:  Fabian H Rossi; Elisa Marie Rossi; Michael Hoffmann; Welwin Liu; Ramon Rodriguez Cruz; Natasha Antonovich; Arash Rezaei; Elizabeth Gonzalez; Maria Clara Franco; Alvaro Estevez; Florian Thomas
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

8.  Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex.

Authors:  R W Licht; J O Larsen; D Smith; H Braendgaard
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

Review 9.  Lithium and cognitive enhancement: leave it or take it?

Authors:  Eleftheria Tsaltas; Dimitris Kontis; Vasileios Boulougouris; George N Papadimitriou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-10       Impact factor: 4.530

10.  Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Authors:  Oksana Kaidanovich-Beilin; Tatiana V Lipina; Keizo Takao; Matthijs van Eede; Satoko Hattori; Christine Laliberté; Mustafa Khan; Kenichi Okamoto; John W Chambers; Paul J Fletcher; Katrina MacAulay; Bradley W Doble; Mark Henkelman; Tsuyoshi Miyakawa; John Roder; James R Woodgett
Journal:  Mol Brain       Date:  2009-11-19       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.